Safety and efficacy of dual versus triple antithrombotic therapy (DAT vs TAT) in patients with atrial fibrillation following a PCI: a systematic review and network meta-analysis
Objective Creating an appropriate antithrombotic therapy for patients with atrial fibrillation (AF) who have undergone percutaneous coronary intervention (PCI) remains a dilemma. Several clinical trials compared the use of a dual antithrombotic therapy (DAT) regimen with a direct oral anticoagulants...
Saved in:
Main Authors: | Abdulaali R Almutairi, Renad M Altoukhi, Reema A Alshouimi, Shahad M Al Rammah, Mohammed Y Alzahrani, Abdulmajeed M Alshehri, Osamah M Alfayez, Majed S Al Yami, Omar A Almohammed |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-09-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/10/9/e036138.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating the risk of acute kidney injury and mortality associated with concomitant use of vancomycin with piperacillin/tazobactam or meropenem in critically ill and non-critically ill patients: a systematic review and meta-analysis
by: Abdulmajeed M. Alshehri, et al.
Published: (2025-01-01) -
La 17e nuit d’at-Tawḥīdī
by: Guillaume de Vaulx d’Arcy
Published: (2019-12-01) -
Antithrombotic Medication for Cardioembolic Stroke Prevention
by: M. Àngels Font, et al.
Published: (2011-01-01) -
Langeweile und „Parole der Tat“
by: Sebastian Hüsch
Published: (2014-12-01) -
Dry Needling and Antithrombotic Drugs
by: María Muñoz, et al.
Published: (2022-01-01)